Multidrug resistant osteosarcoma cell lines exhibit deficiency of GADD45α expression

Apoptosis

Volumn 14, Issue 1, 2009, Pages 124-133

  Yang, Cao ^a,b   Yang, Shuhua ^b   Wood, Kirkham B ^a   Hornicek, Francis J ^a   Schwab, Joseph H ^a   Fondren, Gertrude ^a   Mankin, Henry ^a   Duan, Zhenfeng ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Apoptosis; GADD45 ; Multidrug resistance; Osteosarcoma

Indexed keywords

ANTINEOPLASTIC AGENT; CELL CYCLE PROTEIN; GADD45A PROTEIN, HUMAN; NUCLEAR PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BIOLOGICAL MODEL; DNA MICROARRAY; DOSE RESPONSE; DRUG RESISTANCE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HUMAN; METABOLISM; MULTIDRUG RESISTANCE; OSTEOSARCOMA; TIME; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MODELS, BIOLOGICAL; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOSARCOMA; TIME FACTORS; TRANSFECTION;

EID: 58949092519     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-008-0282-x     Document Type: Article

References (36)

1. Schwartz CL, Gorlick R, Teot L, Krailo M, Chen Z, Goorin A et al (2007) Multiple drug resistance in osteogenic sarcoma: INT0133 from the Children's Oncology Group. J Clin Oncol 25:2057-2062. doi:10.1200/JCO.2006.07.7776 (Pubitemid 46972791)
2. Provisor AJ, Ettinger LJ, Nachman JB, Krailo MD, Makley JT, Yunis EJ et al (1997) Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group. J Clin Oncol 15:76-84 (Pubitemid 27020560)
3. Marcove RC, Mike V, Hajek JV, Levin AG, Hutter RV (1970) Osteogenic sarcoma under the age of twenty-one. A review of one hundred and forty-five operative cases. J Bone Joint Surg Am 52:411-423
4. Chou AJ, Gorlick R (2006) Chemotherapy resistance in osteosarcoma: current challenges and future directions. Expert Rev Anticancer Ther 6:1075-1085. doi:10.1586/14737140.6.7.1075 (Pubitemid 44203385)
5. Mimeault M, Hauke R, Batra SK (2008) Recent advances on the molecular mechanisms involved in the drug resistance of cancer cells and novel targeting therapies. Clin Pharmacol Ther 83:673-691. doi:10.1038/sj.clpt.6100296 (Pubitemid 351559599)
6. Hunter AM, LaCasse EC, Korneluk RG (2007) The inhibitors of apoptosis (IAPs) as cancer targets. Apoptosis 12:1543-1568. doi: 10.1007/s10495-007-0087-3 (Pubitemid 47106887)
7. Prabhudesai SG, Rekhraj S, Roberts G, Darzi AW, Ziprin P (2007) Apoptosis and chemo-resistance in colorectal cancer. J Surg Oncol 96:77-88. doi:10.1002/jso.20785 (Pubitemid 47015454)
8. Johnstone RW, Ruefli AA, Lowe SW (2002) Apoptosis: a link between cancer genetics and chemotherapy. Cell 108:153-164. doi:10.1016/S0092-8674(02)00625-6 (Pubitemid 34161136)
9. Makin G, Hickman JA (2000) Apoptosis and cancer chemotherapy. Cell Tissue Res 301:143-152. doi:10.1007/s004419900160 (Pubitemid 30459861)
10. Duan Z, Feller AJ, Penson RT, Chabner BA, Seiden MV (1999) Discovery of differentially expressed genes associated withpaclitaxel resistance using cDNA array technology: analysis of interleukin (IL) 6, IL-8, and monocyte chemotactic protein 1 in the paclitaxel-resistant phenotype. Clin Cancer Res 5:3445-3453
11. Lourda M, Trougakos IP, Gonos ES (2007) Development of resistance to chemotherapeutic drugs in human osteosarcoma cell lines largely depends on up-regulation of Clusterin/Apolipoprotein J. Int J Cancer 120:611-622. doi:10.1002/ijc.22327 (Pubitemid 44969033)
12. Duan Z, Duan Y, Lamendola DE, Yusuf RZ, Naeem R, Penson RT et al (2003) Overexpression of MAGE/GAGE genes in paclitaxel/ doxorubicin-resistant human cancer cell lines. Clin Cancer Res 9:2778-2785 (Pubitemid 36842124)
13. Elstein KH, Zucker RM (1994) Comparison of cellular and nuclear flow cytometric techniques for discriminating apoptotic subpopulations. Exp Cell Res 211:322-331. doi:10.1006/excr. 1994.1094 (Pubitemid 24174964)
14. Darzynkiewicz Z, Juan G, Li X, Gorczyca W, Murakami T, Traganos F (1997) Cytometry in cell necrobiology: analysis of apoptosis and accidental cell death (necrosis). Cytometry 27:1-20. doi:10.1002/(SICI)1097-0320(19970101)27:1\1::AID- CYTO2[ 3.0.CO;2-L (Pubitemid 27059777)
15. Belloc F, Dumain P, Boisseau MR, Jalloustre C, Reiffers J, Bernard P et al (1994) A flow cytometric method using Hoechst 33342 and propidium iodide for simultaneous cell cycle analysis and apoptosis determination in unfixed cells. Cytometry 17:59-65. doi:10.1002/cyto.990170108
16. Jiang T, Soprano DR, Soprano KJ (2007) GADD45A is a mediator of CD437 induced apoptosis in ovarian carcinoma cells. J Cell Physiol 212:771-779. doi:10.1002/jcp.21073 (Pubitemid 47267546)
17. Hsu CA, Rishi AK, Su-Li X, Gerald TM, Dawson MI, Schiffer C et al (1997) Retinoid induced apoptosis in leukemia cells through a retinoic acid nuclear receptor-independent pathway. Blood 89:4470-4479 (Pubitemid 27260257)
18. Rishi AK, Sun RJ, Gao Y, Hsu CK, Gerald TM, Sheikh MS et al (1999) Post-transcriptional regulation of the DNA damageinducible gadd45 gene in human breast carcinoma cells exposed to a novel retinoid CD437. Nucleic Acids Res 27:3111-3119. doi: 10.1093/nar/27.15.3111 (Pubitemid 29355725)
19. Lievre A, Bachet JB, Boige V, Cayre A, Le Corre D, Buc E et al (2008) KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab. J Clin Oncol 26:374-379. doi:10.1200/JCO.2007.12.5906 (Pubitemid 351171687)
20. Smith GB, Mocarski ES (2005) Contribution of GADD45 family members to cell death suppression by cellular Bcl-xL and cytomegalovirus vMIA. J Virol 79:14923-14932. doi:10.1128/JVI.79. 23.14923-14932.2005 (Pubitemid 41636289)
21. Takekawa M, Saito H (1998) A family of stress-inducible GADD45-like proteins mediate activation of the stress-responsive MTK1/MEKK4 MAPKKK. Cell 95:521-530. doi:10.1016/ S0092-8674(00)81619-0 (Pubitemid 28533308)
22. Miyake Z, Takekawa M, Ge Q, Saito H (2007) Activation of MTK1/MEKK4 by GADD45 through induced N-C dissociation and dimerization-mediated trans autophosphorylation of the MTK1 kinase domain. Mol Cell Biol 27:2765-2776. doi:10.1128/ MCB.01435-06 (Pubitemid 46581364)
23. Tront JS, Hoffman B, Liebermann DA (2006) Gadd45a suppresses Ras-driven mammary tumorigenesis by activation of c-Jun NH2- terminal kinase and p38 stress signaling resulting in apoptosis and senescence. Cancer Res 66:8448-8454. doi:10.1158/0008-5472. CAN-06-2013 (Pubitemid 44449156)
24. Fayette J, Blay JY (2005) Genetic predictors for drug resistance in soft tissue sarcoma: a review of publications in 2004. Curr Opin Oncol 17:370-375. doi:10.1097/01.cco.0000166650.30793.f2 (Pubitemid 40904425)
25. Sherr CJ (2004) Principles of tumor suppression. Cell 116:235-246. doi:10.1016/S0092-8674(03)01075-4 (Pubitemid 38167315)
26. Weinstein JN, Myers TG, O'Connor PM, Friend SH, Fornace AJ Jr., Kohn KW et al (1997) An information-intensive approach to the molecular pharmacology of cancer. Science 275:343-349. doi:10.1126/science.275.5298.343 (Pubitemid 27051604)
27. Wong RP, Tsang WP, Chau PY, Co NN, Tsang TY, Kwok TT (2007) p53-R273H gains new function in induction of drug resistance through down-regulation of procaspase-3. Mol Cancer Ther 6:1054-1061. doi:10.1158/1535-7163.MCT-06-0336 (Pubitemid 46554576)
28. Pakos EE, Kyzas PA, Ioannidis JP (2004) Prognostic significance of TP53 tumor suppressor gene expression and mutations in human osteosarcoma: a meta-analysis. Clin Cancer Res 10:6208-6214. doi:10.1158/1078-0432.CCR-04-0246 (Pubitemid 39287528)
29. Harkin DP, Bean JM, Miklos D, Song YH, Truong VB, Englert C et al (1999) Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1. Cell 97: 575-586. doi:10.1016/S0092-8674(00)80769-2 (Pubitemid 29256961)
30. Chen F, Zhang Z, Leonard SS, Shi X (2001) Contrasting roles of NF-kappaB and JNK in arsenite-induced p53-independent expression of GADD45alpha. Oncogene 20:3585-3589. doi: 10.1038/sj.onc.1204442 (Pubitemid 32619413)
31. Liu F, Xie ZH, Cai GP, Jiang YY (2007) The effect of survivin on multidrug resistance mediated by P-glycoprotein in MCF-7 and its adriamycin resistant cells. Biol Pharm Bull 30:2279-2283. doi:10.1248/bpb.30.2279 (Pubitemid 350223727)
32. Sturm I, Petrowsky H, Volz R, Lorenz M, Radetzki S, Hillebrand T et al (2001) Analysis of p53/BAX/p16(ink4a/CDKN2) in esophageal squamous cell carcinoma: high BAX and p16(ink4a/ CDKN2) identifies patients with good prognosis. J Clin Oncol 19:2272-2281 (Pubitemid 32366980)
33. Violette S, Poulain L, Dussaulx E, Pepin D, Faussat AM, Chambaz J et al (2002) Resistance of colon cancer cells to longterm 5-fluorouracil exposure is correlated to the relative level of Bcl-2 and Bcl-X(L) in addition to Bax and p53 status. Int J Cancer 98:498-504. doi:10.1002/ijc.10146 (Pubitemid 34208549)
34. Li YC, Tzeng CC, Song JH, Tsia FJ, Hsieh LJ, Liao SJ et al (2006) Genomic alterations in human malignant glioma cells associate with the cell resistance to the combination treatment with tumor necrosis factor-related apoptosis-inducing ligand and chemotherapy. Clin Cancer Res 12:2716-2729. doi:10.1158/ 1078-0432.CCR-05-1980
35. Matsuyama R, Togo S, Shimizu D, Momiyama N, Ishikawa T, Ichikawa Y et al (2006) Predicting 5-fluorouracil chemosensitivity of liver metastases from colorectal cancer using primary tumor specimens: three-gene expression model predicts clinical response. Int J Cancer 119:406-413. doi:10.1002/ijc.21843
36. Zhang M, Guo R, Zhai Y, Yang D (2003) LIGHT sensitizes IFNgamma-mediated apoptosis of MDA-MB-231 breast cancer cells leading to down-regulation of anti-apoptosis Bcl-2 family members. Cancer Lett 195:201-210 (Pubitemid 36603330)